Streetbeat News

Stock Prices

SOLUSD

Solana (SOLUSD) is trading lower due to overall weakness in the cryptocurrency market, exacerbated by market volatility following Iran's recent attack on Israel, which could affect risk sentiment.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 5:07 pm

ETHUSD

Ethereum (ETHUSD) is trading lower due to overall crypto market weakness, exacerbated by recent geopolitical tensions following Iran's attack on Israel, which has increased market volatility and could affect risk sentiment.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 5:06 pm

BTCUSD

Bitcoin's price has declined due to increased market volatility following Iran's recent attack on Israel, affecting risk sentiment.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 5:06 pm

TSM

Financial giants have shown a bullish stance on Taiwan Semiconductor (NYSE:TSM) with 61 unusual trades, indicating a price target range of $115 to $195 over the next three months. The analysis revealed a mix of bullish and bearish sentiments among traders, with a significant lean towards bullish positions. Notable options activity and expert opinions suggest a positive outlook for TSM, with analysts setting an average target price of $164.33. The company's market leadership and strong customer base, including major tech firms, support its solid operating margins.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:01 pm

CI

Financial analysts have observed a bullish trend in options trading for Cigna Group (NYSE:CI), with 72% of trades being bullish. The trading activity suggests a target price range of $270 to $390. The analysis includes a detailed review of call and put volumes, largest trades, and the company's current market status, including a recent downgrade by Cantor Fitzgerald to Overweight with a target price of $384. Cigna's stock is currently at $349.13, with trading volume at 893,618 and an RSI indicating a neutral position. The company, a major player in health insurance and pharmacy benefit management, is expected to announce earnings in 16 days.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:01 pm

CMG

Over the past 15 years, Chipotle Mexican Grill (NYSE:CMG) has delivered an average annual return of 26.56%, turning a $100 investment into $3,613.76. With a current market capitalization of $80.26 billion, CMG's performance highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:01 pm

AMBA

Analyst evaluations of Ambarella (NASDAQ:AMBA) over the last three months show diverse opinions, with recent actions including ratings adjustments and changes to price targets. The average 12-month price target for AMBA has increased to $73.25, reflecting a positive sentiment shift. Financial indicators reveal challenges for Ambarella, including a significant revenue decline and below-average profitability metrics. Despite a conservative debt management approach, the company's market performance and financial health indicators suggest potential concerns for investors.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:00 pm

WSM

Williams-Sonoma (NYSE:WSM) has significantly outperformed the market with an annualized return of 26.57% over the past 5 years, turning a $100 investment into $504.99 today. The company's market capitalization stands at $18.34 billion.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:00 pm

MRNS

Marinus Pharma (NASDAQ:MRNS) received mixed analyst ratings over the past three months, with a total of 7 analysts providing insights. The ratings ranged from bullish to indifferent, with no bearish views. The 12-month price targets suggest a significant potential upside, with an average target of $20.71, a high of $28.00, and a low of $3.00. This marks a 25.52% increase from the previous average target of $16.50. Analysts' actions included maintaining, lowering, and raising ratings and price targets, reflecting their adaptation to market conditions and company performance.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 5:00 pm

APP

CVS

FCX

On CNBC's Halftime Report, analysts shared their final trades, highlighting Applovin (APP), Freeport-McMoRan (FCX), and CVS Health (CVS) as their top picks.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 5:00 pm